Raymond James & Associates’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $632M | Sell |
|
|||||
|
2024
Q2 | $596M | Buy |
|
|||||
|
2024
Q1 | $632M | Buy |
|
|||||
|
2023
Q4 | $589M | Buy |
|
|||||
|
2023
Q3 | $532M | Buy |
|
|||||
|
2023
Q2 | $477M | Buy |
|
|||||
|
2023
Q1 | $478M | Sell |
|
|||||
|
2022
Q4 | $422M | Buy |
|
|||||
|
2022
Q3 | $444M | Buy |
|
|||||
|
2022
Q2 | $503M | Buy |
|
|||||
|
2022
Q1 | $565M | Buy |
|
|||||
|
2021
Q4 | $525M | Buy |
|
|||||
|
2021
Q3 | $430M | Buy |
|
|||||
|
2021
Q2 | $455M | Buy |
|
|||||
|
2021
Q1 | $408M | Buy |
|
|||||
|
2020
Q4 | $316M | Sell |
|
|||||
|
2020
Q3 | $299M | Sell |
|
|||||
|
2020
Q2 | $294M | Buy |
|
|||||
|
2020
Q1 | $288M | Buy |
|
|||||
|
2019
Q4 | $316M | Buy |
|
|||||
|
2019
Q3 | $315M | Buy |
|
|||||
|
2019
Q2 | $279M | Buy |
|
|||||
|
2019
Q1 | $223M | Buy |
|
|||||
|
2018
Q4 | $217M | Buy |
|
|||||
|
2018
Q3 | $194M | Buy |
|
|||||
|
2018
Q2 | $179M | Buy |
|
|||||
|
2018
Q1 | $175M | Buy |
|
|||||
|
2017
Q4 | $151M | Buy |
|
|||||
|
2017
Q3 | $136M | Buy |
|
|||||
|
2017
Q2 | $114M | Buy |
|
|||||
|
2017
Q1 | $96.5M | Buy |
|
|||||
|
2016
Q4 | $91.7M | Sell |
|
|||||
|
2016
Q3 | $96.2M | Sell |
|
|||||
|
2016
Q2 | $91.3M | Buy |
|
|||||
|
2016
Q1 | $78.8M | Buy |
|
|||||
|
2015
Q4 | $72M | Buy |
|
|||||
|
2015
Q3 | $63.9M | Buy |
|
|||||
|
2015
Q2 | $60.4M | Buy |
|
|||||
|
2015
Q1 | $53.4M | Sell |
|
|||||
|
2014
Q4 | $59.5M | Buy |
|
|||||
|
2014
Q3 | $48.7M | Buy |
|
|||||
|
2014
Q2 | $39.6M | Sell |
|
|||||
|
2014
Q1 | $42.6M | Buy |
|
|||||
|
2013
Q4 | $38.9M | Buy |
|
|||||
|
2013
Q3 | $27.6M | Sell |
|
|||||
|
2013
Q2 | $30.3M | Buy |
|